Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB · BSE: 532305 · Pharmaceuticals & Biotechnology · 39 announcements

Share price: ₹391.00
Market cap: ₹3,400 Cr
Revenue (annual): ₹641.3 Cr
Net profit (annual): ₹41.42 Cr
P/E (TTM): 59.3×Sector 47.4×
Promoter holding: 42.93%-0.06% QoQ
FII holding: 10.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 8 Capital Structure Change 6 Annual General Meeting 6 Price Movement Clarification 3 Financial Results 3 Board Meeting Date 3 Employee Stock Options 2 Capacity Expansion 2 Results Update 1 Management Change 1 Fund Raise 1 Earnings Call 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

18 Aug 2026 18:25 IST NSE

Capacity Expansion

Ind-Swift Laboratories Capacity Expansion: ₹45 Cr Investment

Ind-Swift Laboratories will invest Rs. 45 crore to upgrade its Jammu facility to EU-GMP standards. This expansion targets additional annual revenue of Rs. 100 crore by 2029-30.

Value: ₹45.00 Cr

Read the filing ↗

28 Jul 2026 19:17 IST BSE

Capacity Expansion

Ind-Swift Laboratories Capacity Expansion: ₹40 Cr Investment

Ind-Swift Laboratories entered a ₹40 Crore MOU with Him Infratech to build a warehouse facility in Punjab. The project aims to improve storage and operational efficiencies.

Value: ₹40.00 Cr
Execution: 300 days

Read the filing ↗